DSNKY / Japan's Daiichi Sankyo invests $80 million to expand Brazilian plant

Scotiabank analysts upgrade AT&T (T) stock from "Sector Perform" to "Sector Outperform." Merck (MRK) strikes a deal worth up to $22 billion with Japan more_horizontal

Daiichi Sankyo shares 4568, +12.21% rose sharply after the Japanese drugmaker announced a multibillion dollar deal with Merck MRK, -1.53% to jointly d more_horizontal

Daiichi Sankyo and Merck have entered into an agreement worth up to $22 billion for three of Daiichi Sankyo's DXd antibody drug conjugate (ADC) candid more_horizontal

Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q1 2023 Earnings Conference Call July 31, 2023 2:00 AM ET Company Participants Kentaro Asakura - Vice Pr more_horizontal

A Japanese health ministry panel recommended approval for Daiichi Sankyo's mRNA-based COVID-19 vaccine in what would be the nation's first home-grown more_horizontal

The U.S. Food and Drug Administration (FDA) approved Japan-based Daiichi Sankyo Co's treatment for newly diagnosed patients with an aggressive type of more_horizontal

Daiichi Sankyo is leading the world in the development of antibody-drug conjugates, which are finally paying off in cancer after more than a decade of more_horizontal

Japanese drugmaker Daiichi Sankyo said on Monday it will invest around 400 million reais ($80 million) to expand its Brazilian operations, part of a p more_horizontal